Skip to main content

Curative Biotechnology Inc

CUBT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001400271

No open-market purchases or sales by Curative Biotechnology Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of CUBT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Curative Biotechnology Inc, largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Curative Biotechnology Inc on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Curative Biotechnology Inc, newest first.

No Schedule 13D or 13G filings on Curative Biotechnology Inc are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Curative Biotechnology Inc shares.

No Form 144 notices for Curative Biotechnology Inc are on file.